After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.
Efficacy and safety of GZR18 injected every 2 weeks (Q2W) in participants without type 2 diabetes, who have obesity or are overweight: a randomized, tirzepatide- and placebo-controlled study